PT84416B - Processo para a preparacao de formas de dosagem de libertacao controlada para administracao oral contendo polissacaridos de origem natural - Google Patents
Processo para a preparacao de formas de dosagem de libertacao controlada para administracao oral contendo polissacaridos de origem naturalInfo
- Publication number
- PT84416B PT84416B PT84416A PT8441687A PT84416B PT 84416 B PT84416 B PT 84416B PT 84416 A PT84416 A PT 84416A PT 8441687 A PT8441687 A PT 8441687A PT 84416 B PT84416 B PT 84416B
- Authority
- PT
- Portugal
- Prior art keywords
- polysacarides
- preparation
- dosage forms
- oral administration
- natural origin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT19675/86A IT1191674B (it) | 1986-03-07 | 1986-03-07 | Formulazioni per la preparazione di farmaci a rilascio prolungato adatte alla somministrazione per via orale |
Publications (2)
Publication Number | Publication Date |
---|---|
PT84416A PT84416A (en) | 1987-04-01 |
PT84416B true PT84416B (pt) | 1989-10-04 |
Family
ID=11160299
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT84416A PT84416B (pt) | 1986-03-07 | 1987-03-06 | Processo para a preparacao de formas de dosagem de libertacao controlada para administracao oral contendo polissacaridos de origem natural |
Country Status (12)
Country | Link |
---|---|
US (1) | US5047248A (pt) |
EP (1) | EP0261213B1 (pt) |
JP (1) | JP2617109B2 (pt) |
KR (1) | KR880701099A (pt) |
CA (1) | CA1316108C (pt) |
DK (1) | DK172117B1 (pt) |
HK (1) | HK12395A (pt) |
IT (1) | IT1191674B (pt) |
NZ (1) | NZ219523A (pt) |
PT (1) | PT84416B (pt) |
WO (1) | WO1987005212A1 (pt) |
ZA (1) | ZA871620B (pt) |
Families Citing this family (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8601204D0 (en) * | 1986-01-18 | 1986-02-19 | Boots Co Plc | Therapeutic agents |
US4994276A (en) * | 1988-09-19 | 1991-02-19 | Edward Mendell Co., Inc. | Directly compressible sustained release excipient |
US5096714A (en) * | 1988-06-28 | 1992-03-17 | Hauser-Kuhrts, Inc. | Prolonged release drug tablet formulations |
US5128143A (en) * | 1988-09-19 | 1992-07-07 | Edward Mendell Co., Inc. | Sustained release excipient and tablet formulation |
US5169639A (en) * | 1988-09-19 | 1992-12-08 | Edward Mendell Co., Inc. | Controlled release verapamil tablets |
US5032406A (en) * | 1989-02-21 | 1991-07-16 | Norwich Eaton Pharmaceuticals, Inc. | Dual-action tablet |
US5478577A (en) * | 1993-11-23 | 1995-12-26 | Euroceltique, S.A. | Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level |
US5292534A (en) * | 1992-03-25 | 1994-03-08 | Valentine Enterprises, Inc. | Sustained release composition and method utilizing xanthan gum and an active ingredient |
US5298261A (en) * | 1992-04-20 | 1994-03-29 | Oregon Freeze Dry, Inc. | Rapidly distintegrating tablet |
NL9201195A (nl) * | 1992-07-03 | 1994-02-01 | Tno | Preparaat voor de gereguleerde afgifte van een werkzame stof en werkwijze ter bereiding van een dergelijk preparaat. |
US5472711A (en) * | 1992-07-30 | 1995-12-05 | Edward Mendell Co., Inc. | Agglomerated hydrophilic complexes with multi-phasic release characteristics |
US5399354A (en) * | 1993-05-28 | 1995-03-21 | Mcneil-Ppc, Inc. | Process for making a hard-candy based oral pharmaceutical lozenge containing an antacid |
US5993860A (en) * | 1993-06-17 | 1999-11-30 | Venture Lending | NSADI delivery employing a powdered hydrocolloid gum obtainable from higher plants |
US6676967B1 (en) | 1993-09-20 | 2004-01-13 | Kos Pharmaceuticals, Inc. | Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia |
US6080428A (en) | 1993-09-20 | 2000-06-27 | Bova; David J. | Nicotinic acid compositions for treating hyperlipidemia and related methods therefor |
US6818229B1 (en) | 1993-09-20 | 2004-11-16 | Kos Pharmaceuticals, Inc. | Intermediate release nicotinic acid compositions for treating hyperlipidemia |
US6129930A (en) | 1993-09-20 | 2000-10-10 | Bova; David J. | Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night |
US6746691B2 (en) | 1993-09-20 | 2004-06-08 | Kos Pharmaceuticals, Inc. | Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics |
FR2729857B1 (fr) | 1995-01-27 | 1997-04-04 | Rhone Poulenc Chimie | Compositions pharmaceutiques sous forme de comprimes a liberation prolongee a base de granules en polysaccharides de haut poids moleculaire |
BE1009380A3 (nl) * | 1995-03-14 | 1997-03-04 | Universiteit Gent Lab Voor Far | Stabiliserend samenstelling voor suspensie. |
AU2068797A (en) * | 1996-01-29 | 1997-08-20 | Edward Mendell Co. Inc. | Sustained release excipient |
US6210710B1 (en) * | 1997-04-28 | 2001-04-03 | Hercules Incorporated | Sustained release polymer blend for pharmaceutical applications |
IN186245B (pt) | 1997-09-19 | 2001-07-14 | Ranbaxy Lab Ltd | |
DE69940557D1 (de) * | 1998-12-11 | 2009-04-23 | Nostrum Pharmaceuticals Inc | Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung |
BR0012869A (pt) * | 1999-07-30 | 2002-05-21 | Smithkline Beecham Plc | Forma de dosagem farmacêutica de componentes múltiplos |
AU3885901A (en) * | 1999-09-21 | 2001-04-24 | Emory University | Methods and compositions for treating platelet-related disorders |
US6372252B1 (en) | 2000-04-28 | 2002-04-16 | Adams Laboratories, Inc. | Guaifenesin sustained release formulation and tablets |
US7838032B2 (en) * | 2000-04-28 | 2010-11-23 | Reckitt Benckiser Inc. | Sustained release of guaifenesin |
US7985420B2 (en) * | 2000-04-28 | 2011-07-26 | Reckitt Benckiser Inc. | Sustained release of guaifenesin combination drugs |
US6955821B2 (en) * | 2000-04-28 | 2005-10-18 | Adams Laboratories, Inc. | Sustained release formulations of guaifenesin and additional drug ingredients |
US8012504B2 (en) * | 2000-04-28 | 2011-09-06 | Reckitt Benckiser Inc. | Sustained release of guaifenesin combination drugs |
ATE376832T1 (de) * | 2001-07-06 | 2007-11-15 | Penwest Pharmaceuticals Co | Verzögert freisetzende formulierungen von oxymorphon |
US8329216B2 (en) | 2001-07-06 | 2012-12-11 | Endo Pharmaceuticals Inc. | Oxymorphone controlled release formulations |
DE60219478T2 (de) * | 2001-07-06 | 2008-01-03 | Endo Pharmaceuticals Inc. | Orale gabe von 6-hydroxy-oxymorphon als analgetikum |
US20040052851A1 (en) * | 2002-09-16 | 2004-03-18 | Graff Allan H. | Modified release oral dosage form |
CA2529984C (en) | 2003-06-26 | 2012-09-25 | Isa Odidi | Oral multi-functional pharmaceutical capsule preparations of proton pump inhibitors |
RS51934B (en) | 2003-08-08 | 2012-02-29 | Biovail Laboratories International Srl. | BUPROPION HYDROCHLORIDE TABLE WITH MODIFIED RELEASE |
GB0320854D0 (en) | 2003-09-05 | 2003-10-08 | Arrow No 7 Ltd | Buccal drug delivery |
US20050053648A1 (en) * | 2003-09-08 | 2005-03-10 | Chalmers Anne Marie | Medication delivery device |
US8394409B2 (en) | 2004-07-01 | 2013-03-12 | Intellipharmaceutics Corp. | Controlled extended drug release technology |
US10624858B2 (en) | 2004-08-23 | 2020-04-21 | Intellipharmaceutics Corp | Controlled release composition using transition coating, and method of preparing same |
AU2006269944A1 (en) * | 2005-07-19 | 2007-01-25 | Inverseon, Inc. | Improved pharmacokinetic profile of beta-adrenergic inverse agonists for the treatment of pulmonary airway diseases |
WO2007055329A1 (ja) | 2005-11-11 | 2007-05-18 | Asahi Kasei Chemicals Corporation | 徐放性固形製剤 |
US10064828B1 (en) | 2005-12-23 | 2018-09-04 | Intellipharmaceutics Corp. | Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems |
JP5457830B2 (ja) | 2006-04-03 | 2014-04-02 | オディディ,イサ | オルガノゾル被膜を含む制御放出送達デバイス |
US10960077B2 (en) | 2006-05-12 | 2021-03-30 | Intellipharmaceutics Corp. | Abuse and alcohol resistant drug composition |
US20080220064A1 (en) * | 2006-12-06 | 2008-09-11 | Ramesh Ketkar Anant | Extended release matrix formulations of morphine |
GB2462022B (en) | 2008-06-16 | 2011-05-25 | Biovascular Inc | Controlled release compositions of agents that reduce circulating levels of platelets and methods thereof |
EP3045043B1 (en) | 2009-02-26 | 2020-04-29 | Relmada Therapeutics, Inc. | Extended release oral pharmaceutical compositions of 3-hydroxy-n-methylmorphinan and method of use |
JP5819329B2 (ja) * | 2010-03-09 | 2015-11-24 | アルカーメス ファーマ アイルランド リミテッド | アルコール耐性腸溶性医薬組成物 |
WO2014014645A1 (en) * | 2012-07-17 | 2014-01-23 | Miranda Technologies, Inc. | Systems and methods for oral administration of a therapy |
WO2017052455A1 (en) | 2015-09-23 | 2017-03-30 | Anara Ab | Amylase fragments for blood glucose control |
CA3001337C (en) | 2015-10-09 | 2023-12-12 | Reckitt Benckiser Llc | Pharmaceutical formulation |
EP3251687A1 (en) | 2016-06-01 | 2017-12-06 | Centrum Innowacji Edoradca Sp. z o.o. Spolka Komandytowa | Bioactive peptides for blood glucose control |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3065143A (en) * | 1960-04-19 | 1962-11-20 | Richardson Merrell Inc | Sustained release tablet |
DE2130545A1 (de) * | 1971-06-19 | 1972-12-21 | Merck Patent Gmbh | Pharmazeutischer Formkoerper |
US4332789A (en) * | 1975-12-15 | 1982-06-01 | Hoffmann-La Roche Inc. | Pharmaceutical unit dosage forms |
US4344857A (en) * | 1975-12-22 | 1982-08-17 | The United States Of America As Represented By The Secretary Of Agriculture | Encapsulation by entrapment |
US4163777A (en) * | 1977-04-29 | 1979-08-07 | Lewis/Howe Company | Controlled antacid delivery form and method of treatment therewith |
US4259341A (en) * | 1977-06-01 | 1981-03-31 | Merck & Co., Inc. | Di- and tri-substituted thiazoles |
US4248858A (en) * | 1979-08-09 | 1981-02-03 | American Home Products Corporation | Sustained release pharmaceutical compositions |
US4375468A (en) * | 1981-07-13 | 1983-03-01 | Verex Laboratories, Inc. | Constant order release aspirin composition and method of treating arthritis |
US4369172A (en) * | 1981-12-18 | 1983-01-18 | Forest Laboratories Inc. | Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose |
US4556678A (en) * | 1982-06-24 | 1985-12-03 | Key Pharmaceuticals, Inc. | Sustained release propranolol tablet |
DE3346571A1 (de) * | 1983-12-23 | 1985-07-04 | Bayer Ag, 5090 Leverkusen | Oral retardierte acetylsalicylsaeureformulierungen |
JPS60174728A (ja) * | 1984-02-22 | 1985-09-09 | Sato Seiyaku Kk | 持効性製剤 |
JPS6124516A (ja) * | 1984-07-12 | 1986-02-03 | Fujisawa Pharmaceut Co Ltd | 持続性錠剤 |
US4610870A (en) * | 1984-10-05 | 1986-09-09 | E. R. Squibb & Sons, Inc. | Controlled release formulation |
GB8426152D0 (en) * | 1984-10-16 | 1984-11-21 | Reckitt & Colmann Prod Ltd | Medicinal compositions |
DE3440288A1 (de) * | 1984-11-05 | 1986-05-07 | Gergely, Gerhard, Dr.-Ing., Wien | Pharmazeutische zubereitung mit einem gehalt an mindestens einer schleimhautreizenden substanz oder dergleichen, insbesondere profen, sowie verfahren zu ihrer herstellung |
BE901111A (fr) * | 1984-11-22 | 1985-03-15 | Benfar Representee Par Vanderl | Composition pharmaceutiques a liberation prolongee, leur procede de preparation et leur utilisation. |
SE8501094D0 (sv) * | 1985-03-06 | 1985-03-06 | Ulf Schroder | Biologiskt aktiv komposition och forfarande for framstellning derav |
GB8507779D0 (en) * | 1985-03-26 | 1985-05-01 | Fujisawa Pharmaceutical Co | Drug carrier |
US4704285A (en) * | 1985-11-18 | 1987-11-03 | The Dow Chemical Company | Sustained release compositions comprising hydroxypropyl cellulose ethers |
GB8601204D0 (en) * | 1986-01-18 | 1986-02-19 | Boots Co Plc | Therapeutic agents |
-
1986
- 1986-03-07 IT IT19675/86A patent/IT1191674B/it active
-
1987
- 1987-03-02 WO PCT/EP1987/000124 patent/WO1987005212A1/en active IP Right Grant
- 1987-03-02 JP JP62502489A patent/JP2617109B2/ja not_active Expired - Fee Related
- 1987-03-02 EP EP87902464A patent/EP0261213B1/en not_active Expired - Lifetime
- 1987-03-02 KR KR1019870701020A patent/KR880701099A/ko not_active Application Discontinuation
- 1987-03-05 NZ NZ219523A patent/NZ219523A/xx unknown
- 1987-03-06 ZA ZA871620A patent/ZA871620B/xx unknown
- 1987-03-06 PT PT84416A patent/PT84416B/pt not_active IP Right Cessation
- 1987-03-06 CA CA000531406A patent/CA1316108C/en not_active Expired - Fee Related
- 1987-11-05 DK DK582287A patent/DK172117B1/da not_active IP Right Cessation
-
1989
- 1989-02-08 US US07/308,120 patent/US5047248A/en not_active Expired - Fee Related
-
1995
- 1995-01-26 HK HK12395A patent/HK12395A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
IT1191674B (it) | 1988-03-23 |
DK582287D0 (da) | 1987-11-05 |
KR880701099A (ko) | 1988-07-25 |
EP0261213A1 (en) | 1988-03-30 |
AU603098B2 (en) | 1990-11-08 |
PT84416A (en) | 1987-04-01 |
JPS63503225A (ja) | 1988-11-24 |
AU7288387A (en) | 1987-09-28 |
IT8619675A1 (it) | 1987-09-07 |
IT8619675A0 (it) | 1986-03-07 |
NZ219523A (en) | 1990-08-28 |
JP2617109B2 (ja) | 1997-06-04 |
WO1987005212A1 (en) | 1987-09-11 |
HK12395A (en) | 1995-02-03 |
CA1316108C (en) | 1993-04-13 |
DK582287A (da) | 1987-11-05 |
ZA871620B (en) | 1988-02-24 |
EP0261213B1 (en) | 1992-08-05 |
DK172117B1 (da) | 1997-11-17 |
US5047248A (en) | 1991-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT84416B (pt) | Processo para a preparacao de formas de dosagem de libertacao controlada para administracao oral contendo polissacaridos de origem natural | |
PT91731A (pt) | Processo para a preparacao de composicoes farmaceuticas contendo ciclosporinas | |
PT83756B (pt) | Processo para a preparacao de composicoes farmaceuticas com libertacao controlada | |
PT88099A (pt) | Processo para a preparacao de composicoes farmaceuticas de acetaminofeno orais e de libertacao prolongada | |
PT88261A (pt) | Processo para a preparacao de nucleosidos com efeito terapeutico | |
PT84785B (pt) | Processo para a preparacao de composicoes farmceuticas que contem omeprazole para administracao por via oral | |
BR8806789A (pt) | Processo para a preparacao de um polibuteno | |
PT88612A (pt) | Processo para a preparacao de composicoes farmaceuticas contendo um agente anti-calculo dental | |
PT90120A (pt) | Processo para a preparacao de uma composicao farmaceutica contendo deprenil para administracao sistemica transdermica | |
PT87958A (pt) | Processo para a preparacao de composicoes farmaceuticas, contendo antagonistas 5ht-3 | |
NO171828C (no) | Fremgangsmaate for fremstilling av et stabilisert farmasoeytisk preparat inneholdende en granulocyttkolonistimulerende faktor | |
PT88225A (pt) | Processo para a preparacao de formulacoes farmaceuticas contendo di-hidropiridinas | |
BR8702527A (pt) | Processo para a preparacao de uma triazol-sulfonamida | |
PT86986A (pt) | Substituted 9-amino-tetrahydroacridines and related compounds a process for their preparation and their use as medicaments | |
PT90708A (pt) | Processo para a preparacao de derivados de benzopirano | |
PT84561B (pt) | Processo aperfeicoado para a preparacao de derivados macrolidos | |
PT92120A (pt) | Processo para a preparacao de composicoes oftalmologicas contendo ciclosporina | |
PT90888A (pt) | Processo para a preparacao de composicoes farmaceuticas contendo prostaglandinas | |
NO173590C (no) | Fremgangsmaate for fremstilling av et stabilt nikorandilholdig farmasoeytisk preparat | |
BR8707028A (pt) | Processo para a preparacao de mercaptometilfenois | |
PT92242A (pt) | Processo para a preparacao de um analogo de fluoxetina | |
PT90224A (pt) | Processo para a preparacao de composicoes sinergicas contendo imazalilo | |
PT84072B (pt) | Processo para a preparacao de esteroides aminoglicosidicos | |
BR8702278A (pt) | Processo para a preparacao de um composto e composicao | |
PT82585B (pt) | Processo para a preparacao de composicoes funcigidas e algicidas contendo derivados de piridazinio |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PD3A | Change of proprietorship | ||
TE3A | Change of address (patent) | ||
MM3A | Annulment or lapse |
Free format text: LAPSE DUE TO NON-PAYMENT OF FEES Effective date: 20040913 |